Effect of pronase on high-incidence blood group antigens and the prevalence of antibodies to pronase-treated erythrocytes
By: M.E. Reid, C.A. Green, J. Hoffer and R. Øyen
Paid access
|Nov 2020Authors
M.E. Reid
Immunohematology Laboratory, New York Blood Center, New York, United States
C.A. Green
MRC Blood Group Unit, London, UK
J. Hoffer
Immunohematology Laboratory, New York, United States
R. Øyen
Technical Director of Immunohematology Laboratory, New York Blood Center, New York, United States
DOI: https://doi.org/10.21307/immunohematology-2019-767 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 139 - 142
Published on: Nov 16, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 M.E. Reid, C.A. Green, J. Hoffer, R. Øyen, published by American National Red Cross
This work is licensed under the Creative Commons License.